Curis Inc. Unveils Exciting Findings at the 30th Annual SNO Meeting#United_States#Lexington#Curis#emavusertib#SNO_Meeting
Curis Inc. Unveils Exciting Findings at the 30th Annual SNO Meeting
Curis, Inc. will present groundbreaking clinical and preclinical data on emavusertib at the upcoming 30th SNO Meeting in November 2025.
third-news.com
November 14, 2025 at 2:42 PM
Curis Inc. Unveils Exciting Findings at the 30th Annual SNO Meeting#United_States#Lexington#Curis#emavusertib#SNO_Meeting